Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

JOURNAL ARTICLE published August 2010 in The Lancet

Authors: Yung-Jue Bang | Eric Van Cutsem | Andrea Feyereislova | Hyun C Chung | Lin Shen | Akira Sawaki | Florian Lordick | Atsushi Ohtsu | Yasushi Omuro | Taroh Satoh | Giuseppe Aprile | Evgeny Kulikov | Julie Hill | Michaela Lehle | Josef Rüschoff | Yoon-Koo Kang